Research and development is a critical factor for the future of many northern manufacturing industries. Mayne Pharma is a great model for the economic future of northern Adelaide. A sustainable business in the growing health and medical sector, Mayne Pharma is a specialist pharmaceutical company that develops and manufactures branded and generic products and distributes them globally.
The company, which works with the University of South Australia, Flinders University and the University of Adelaide to develop and analyse new products, invested $17 million in research in 2014, a 400 per cent increase from 2012. It also sponsors eight different prizes and awards and provides work placements for up to three students per year.
This increase in research investment has mirrored recent company growth, with more than 60 additional people employed at the Salisbury site in the past three years, an increase of about 25 per cent.
The company has recently installed a large scale fluid bed spray coater at its Salisbury manufacturing facility, thanks in part to a $4 million Next Generation Manufacturing Investment Program grant from the Australian Government and the South Australian State Governments. The grant will allow Mayne Pharma to double its export products to support expected growth in demand.